We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





DeepSight Demonstrates Groundbreaking Ultrasound-Guided Needle Technology

By MedImaging International staff writers
Posted on 26 Nov 2023
Image: DeepSight’s NeedleVue ultrasound-assisted needle guidance technology is on display at RSNA 2023 (Photo courtesy of DeepSight)
Image: DeepSight’s NeedleVue ultrasound-assisted needle guidance technology is on display at RSNA 2023 (Photo courtesy of DeepSight)

DeepSight Technology (Santa Clara, CA, USA) is presenting its groundbreaking NeedleVue solution at RSNA 2023, providing a comprehensive insight into how this technology is poised to reshape and revolutionize the future of interventional procedures. This state-of-the-art ultrasound-guided needle technology ushers in a new era of precision and safety in the field of directed interventional tool guidance which has been struggling with complexities for several decades.

DeepSight's proprietary NeedleVue solution integrates innovative sensor technology with most interventional devices, facilitating real-time verification of placement and significantly reducing procedural guesswork. Conventional technologies usually create challenges like laborious calibration processes, reduced sensitivity, and the need for precise angles of incidence. NeedleVue delivers improvement across the board with its omnidirectional functionality at any plausible ultrasound depth, enhancing functionality and ease of use in a true "plug-and-play" solution.

DeepSight's NeedleVue helps achieve confident results by eliminating guesswork and ensuring verifiable placement in real time. This plug-and-play system eliminates the need for complicated setups or extensive training while its omnifunctionality at any ultrasound depth broadens the scope of its applicability across various medical scenarios. DeepSight's NeedleVue marks a clear paradigm shift in needle guidance technology by delivering real-time, precision needle tracking that is as portable as it is easy to use. The technology meets the need for combining operational efficacy with optimized patient outcomes among healthcare providers.

"NeedleVue not only signifies a monumental leap in the evolution of interventional tool guidance but also substantiates our steadfast commitment to ensuring procedural success - benefiting patients, clinicians, and healthcare providers alike,” said Nader Sadrzadeh, the Chief Executive Officer at DeepSight Technology. “In a reality where procedural confidence is paramount, our solution stands out as a beacon of precision and reliability, effortlessly aligning with the multifaceted demands of modern healthcare."

Related Links:
DeepSight Technology

Adjustable Mobile Barrier
M-458
Multi-Use Ultrasound Table
Clinton
Biopsy Software
Affirm® Contrast
Portable X-ray Unit
AJEX140H

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.